Provided by Tiger Trade Technology Pte. Ltd.

Edwards Lifesciences

85.52
+1.151.36%
Post-market: 85.520.00000.00%19:30 EDT
Volume:2.99M
Turnover:255.66M
Market Cap:49.31B
PE:49.75
High:86.26
Open:85.45
Low:85.12
Close:84.37
52wk High:96.29
52wk Low:72.30
Shares:576.54M
Float Shares:575.03M
Volume Ratio:0.99
T/O Rate:0.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.72
EPS(LYR):1.83
ROE:9.18%
ROA:8.37%
PB:4.64
PE(LYR):46.66

Loading ...

Citi Keeps Their Buy Rating on Edwards Lifesciences (EW)

TIPRANKS
·
Jul 08

HII is Assessed “Awardable” in the U.S. Department of War CDAO Tradewinds Solutions Marketplace

GlobeNewswire
·
Jul 07

Edwards Lifesciences is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Jul 07

Evercore ISI Adjusts Price Target on Edwards Lifesciences to $100 From $93

MT Newswires Live
·
Jul 06

Carvolix Says Edwards Lifesciences Holding Lifts Stake to 11.65% of Capital, 9.07% Voting Rights

Reuters
·
Jul 06

Edwards Lifesciences Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 02

Edwards Lifesciences CVP Daniel J. Lippis Disposes of Common Shares Worth $56,596.72

Reuters
·
Jul 01

Edwards Lifesciences is Maintained at Buy by BTIG

Dow Jones
·
Jun 30

VisionWave Signs Definitive Agreement to Acquire Controlling Interest in Meteor Aerospace

GlobeNewswire
·
Jun 30

BTIG Keeps Their Buy Rating on Edwards Lifesciences (EW)

TIPRANKS
·
Jun 30

BTIG Adjusts Price Target on Edwards Lifesciences to $110 From $100, Maintains Buy Rating

MT Newswires Live
·
Jun 30

Edwards Lifesciences Secures US FDA Approval for Ecliptis System

MT Newswires Live
·
Jun 30

BTIG says AtriCure should be ready to defend AtriClip share after Edwards nod

TIPRANKS
·
Jun 30

FDA posts approval of Edwards left atrial appendage system

TIPRANKS
·
Jun 30

Edwards Lifesciences Can Sustain Strong Revenue Growth on Technological Leadership, RBC Says

MT Newswires Live
·
Jun 30

Edwards Lifesciences Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 27

Edwards Lifesciences Posts Progress Trial Baseline Data on Moderate Aortic Stenosis Patients at New York Valves 2026

Reuters
·
Jun 26

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Edwards Lifesciences (EW), Encompass Health (EHC) and Moderna (MRNA)

TIPRANKS
·
Jun 26

Edwards Lifesciences Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 25

Movement Alert|Edwards Lifesciences Rises 3.53% in Regular Trading, CMS TAVR National Coverage Determination Memo Continues to Serve as Positive Catalyst

Market Focus
·
Jun 24